K231137

Substantially Equivalent

Xenta Drug Screen Cup, Xenta Drug Screen Dipcard

Applicant: Xenta Biomedical Science Co., Ltd.
Product code: DKZ
Advisory panel: Clinical Toxicology
Date received: 2023-04-21
Decision date: 2023-05-19
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Guangzhou, CN

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.